BioCardia, Inc. (BCDA) Debt Components
- 2020-09-30: Notes Payable, CurrentUSD $284.00K; Notes PayableUSD (m); Notes Payable, Related Parties, CurrentUSD (m).
- 2020-06-30: Notes Payable, CurrentUSD $226.00K; Notes PayableUSD (m); Notes Payable, Related Parties, CurrentUSD (m).
- 2017-09-30: Notes Payable, CurrentUSD (m); Notes PayableUSD $0.00; Notes Payable, Related Parties, CurrentUSD (m).
- 2017-06-30: Notes Payable, CurrentUSD (m); Notes PayableUSD $0.00; Notes Payable, Related Parties, CurrentUSD (m).
BioCardia, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Notes Payable USD | Notes Payable, Related Parties, Current USD |
|---|---|---|---|
| 2020-09-30 | $284.00K | (m) | (m) |
| 2020-06-30 | $226.00K | (m) | (m) |
| 2017-09-30 | (m) | $0.00 | (m) |
| 2017-06-30 | (m) | $0.00 | (m) |
| 2017-03-31 | (m) | $0.00 | (m) |
| 2011-12-31 | (m) | (m) | $0.00 |
| 2011-09-30 | (m) | (m) | $0.00 |
| 2011-06-30 | (m) | (m) | $0.00 |
| 2010-12-31 | (m) | (m) | $300.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |